X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (603) 603
male (470) 470
gastroenterology & hepatology (375) 375
female (355) 355
intragastric ph (338) 338
index medicus (294) 294
adult (280) 280
omeprazole (258) 258
pharmacology & pharmacy (253) 253
animals (239) 239
middle aged (224) 224
proton pump inhibitors (222) 222
hydrogen-ion concentration (158) 158
rats (129) 129
aged (127) 127
lansoprazole (118) 118
treatment outcome (117) 117
medicine & public health (116) 116
ranitidine (107) 107
anti-ulcer agents - therapeutic use (106) 106
anti-ulcer agents - administration & dosage (105) 105
helicobacter pylori (102) 102
gastric acidity determination (100) 100
gastric acid - metabolism (98) 98
gastric acid - secretion (93) 93
rabeprazole (93) 93
intragastric acidity (91) 91
surgery (89) 89
cross-over studies (87) 87
time factors (87) 87
gastroesophageal-reflux disease (86) 86
gastroesophageal reflux - drug therapy (85) 85
2-pyridinylmethylsulfinylbenzimidazoles (82) 82
anti-ulcer agents - pharmacology (82) 82
obesity (81) 81
omeprazole - administration & dosage (80) 80
administration, oral (76) 76
gastroenterology (74) 74
rats, sprague-dawley (74) 74
gastroesophageal reflux (73) 73
proton pump inhibitor (73) 73
double-blind (71) 71
dose-response relationship, drug (70) 70
omeprazole - analogs & derivatives (70) 70
helicobacter-pylori infection (67) 67
double-blind method (65) 65
esomeprazole (65) 65
intragastric distribution (65) 65
duodenal-ulcer (64) 64
omeprazole - therapeutic use (64) 64
pharmacokinetics (64) 64
stomach (62) 62
gastroesophageal reflux disease (61) 61
intragastric balloon (60) 60
drug administration schedule (58) 58
omeprazole - pharmacology (58) 58
pantoprazole (58) 58
gastric emptying (57) 57
therapy (57) 57
young adult (55) 55
secretion (54) 54
gastric mucosa - drug effects (53) 53
neurosciences (52) 52
prospective studies (52) 52
oncology (51) 51
adolescent (50) 50
disease (50) 50
endoscopy (50) 50
helicobacter infections - drug therapy (50) 50
hepatology (50) 50
biochemistry, general (49) 49
care and treatment (48) 48
analysis (46) 46
esophagitis (44) 44
functional dyspepsia (44) 44
infection (43) 43
stomach - drug effects (43) 43
proton pump inhibitors - administration & dosage (42) 42
famotidine (41) 41
histamine h2 antagonists - therapeutic use (41) 41
management (41) 41
risk factors (41) 41
symptoms (41) 41
transplant surgery (41) 41
health aspects (40) 40
acid suppression (39) 39
injections, intravenous (39) 39
metabolism (39) 39
mice (39) 39
peptic ulcer (39) 39
weight loss (39) 39
acid (38) 38
medicine, general & internal (38) 38
2-pyridinylmethylsulfinylbenzimidazoles - administration & dosage (37) 37
anti-ulcer agents - pharmacokinetics (37) 37
gastric emptying - physiology (37) 37
gastric mucosa - metabolism (37) 37
peptic-ulcer (37) 37
ulcers (37) 37
weight-loss (37) 37
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ADVANCES IN THERAPY, ISSN 0741-238X, 11/2018, Volume 35, Issue 11, pp. 2024 - 2040
IntroductionReflux symptoms are frequently associated with esophageal acid exposure. However, other potential causes unrelated to acid secretion are possible,... 
MEDICINE, RESEARCH & EXPERIMENTAL | LANSOPRAZOLE | DOSE-RESPONSE | SYMPTOMS | SUPPRESSION | PANTOPRAZOLE | ESOPHAGITIS | GASTROESOPHAGEAL-REFLUX DISEASE | Esomeprazole | Gastroenterology | Intragastric pH | Frequent heartburn | PHARMACOLOGY & PHARMACY | QUALITY-OF-LIFE | GASTRIC-ACIDITY | OMEPRAZOLE 40 MG
Journal Article
Therapeutic Advances in Gastroenterology, ISSN 1756-283X, 11/2015, Volume 8, Issue 6, pp. 322 - 330
Objectives: In mild gastroesophageal reflux disease, which accounts for the great majority of cases, the major burden of reflux occurs during daytime hours,... 
proton pump inhibitors | esomeprazole | gastric acid inhibitors | intragastric pH | gastroesophageal reflux | NIGHTTIME HEARTBURN | LANSOPRAZOLE | RABEPRAZOLE | SLEEP | DOSE-RESPONSE | OMEPRAZOLE | SYMPTOMS | PANTOPRAZOLE | GASTROESOPHAGEAL-REFLUX DISEASE | GASTROENTEROLOGY & HEPATOLOGY | Original Research
Journal Article
Scandinavian Journal of Gastroenterology, ISSN 0036-5521, 2007, Volume 42, Issue 2, pp. 157 - 164
Journal Article
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 06/2018, Volume 16, Issue 6, pp. 800 - 808.e7
Journal Article
The Tohoku Journal of Experimental Medicine, ISSN 0040-8727, 2019, Volume 247, Issue 1, pp. 19 - 25
Patients with laryngopharyngeal reflux (LPR) were reported to suffer from hypogeusia that affects quality of life. Proton pump inhibitor (PPI) is a useful drug... 
histamine H2 receptor antagonist | gustation test | gastroesophageal reflux disease | proton pump inhibitor | taste disturbance | MEDICINE, RESEARCH & EXPERIMENTAL | ESOMEPRAZOLE | LANSOPRAZOLE | ACID CONTROL | OMEPRAZOLE | PEPSIN | 20 MG | MEDICINE, GENERAL & INTERNAL | INTRAGASTRIC PH | IN-VITRO | DISEASE | FAMOTIDINE
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 12/2013, Volume 28, Issue 12, pp. 1823 - 1828
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 2018, Volume 12, pp. 2775 - 2783
Purpose: This study investigated the safety and efficacy of fixed-dose combination tablets of naproxen/esomeprazole magnesium and nimesulide/pantoprazole to... 
Osteoarticular diseases | Nimesulide | Pantoprazole | Randomized controlled trial | Esomeprazole | Naproxen | LANSOPRAZOLE | esomeprazole | CHEMISTRY, MEDICINAL | nimesulide | osteoarticular diseases | randomized controlled trial | naproxen | pantoprazole | INTRAGASTRIC ACID CONTROL | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | NSAIDS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | PANTOPRAZOLE 40 MG | OSTEOARTHRITIS | Dyspepsia - drug therapy | Tablets - administration & dosage | Tablets - therapeutic use | Double-Blind Method | Esomeprazole - administration & dosage | Humans | Middle Aged | Pain Management | Male | Osteoporosis - drug therapy | Naproxen - therapeutic use | Pantoprazole - administration & dosage | Esomeprazole - therapeutic use | Dose-Response Relationship, Drug | Sulfonamides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Pain - drug therapy | Naproxen - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Female | Pantoprazole - therapeutic use | Sulfonamides - administration & dosage | Medical research | Care and treatment | Pain | Medicine, Experimental | Dosage and administration | Nausea | Drug therapy, Combination | Comparative analysis | Osteoarthritis | Patient compliance | Discomfort | Tablets | Dyspepsia | Colleges & universities | Arthritis | Patients | Abdomen | Burning | Omeprazole | Incineration | Biocompatibility | Magnesium | Safety | Questionnaires | Bursitis | Drug dosages | Signs and symptoms | Acids | Tendinitis | Ulcers
Journal Article